- Home
- GRWG vs ANL Comparison
GRWG vs ANL Comparison
Compare GRWG & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- ANL
- Stock Information
- Founded
- GRWG 2008
- ANL 2004
- Country
- GRWG United States
- ANL Cayman Islands
- Employees
- GRWG N/A
- ANL N/A
- Industry
- GRWG RETAIL: Building Materials
- ANL
- Sector
- GRWG Consumer Discretionary
- ANL
- Exchange
- GRWG Nasdaq
- ANL Nasdaq
- Market Cap
- GRWG 102.4M
- ANL 115.1M
- IPO Year
- GRWG N/A
- ANL 2023
- Fundamental
- Price
- GRWG $1.85
- ANL $2.77
- Analyst Decision
- GRWG Hold
- ANL Strong Buy
- Analyst Count
- GRWG 5
- ANL 2
- Target Price
- GRWG $2.75
- ANL $9.00
- AVG Volume (30 Days)
- GRWG 715.8K
- ANL 29.8K
- Earning Date
- GRWG 11-12-2024
- ANL 08-08-2024
- Dividend Yield
- GRWG N/A
- ANL N/A
- EPS Growth
- GRWG N/A
- ANL N/A
- EPS
- GRWG N/A
- ANL N/A
- Revenue
- GRWG $200,882,000.00
- ANL $5,000,000.00
- Revenue This Year
- GRWG N/A
- ANL N/A
- Revenue Next Year
- GRWG N/A
- ANL N/A
- P/E Ratio
- GRWG N/A
- ANL N/A
- Revenue Growth
- GRWG N/A
- ANL N/A
- 52 Week Low
- GRWG $1.55
- ANL $1.85
- 52 Week High
- GRWG $3.38
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- GRWG 45.80
- ANL 53.97
- Support Level
- GRWG $1.67
- ANL $2.50
- Resistance Level
- GRWG $2.00
- ANL $3.50
- Average True Range (ATR)
- GRWG 0.15
- ANL 0.47
- MACD
- GRWG -0.01
- ANL -0.00
- Stochastic Oscillator
- GRWG 42.69
- ANL 40.48
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.